Mixed model stability analysis
...nsellable?” (Side note: I’m going to be framing this in the context of pharma development, but the concepts apply to many different domains.) The challenge comes from the idea that we generally think we m...
...nsellable?” (Side note: I’m going to be framing this in the context of pharma development, but the concepts apply to many different domains.) The challenge comes from the idea that we generally think we m...
Single attributes sampling plans or MIL-STD-105E are used when the inspections can only be classified as two outcomes. One can think of this type of plan as go / no-go or in specification ...
JMP 18を使うと、すぐにレポートのアウトライン右側に★(星)マークのアイコンがあることに気づきます。このアイコンが、本ブログの主役となる「プラットフォームのプリセット」です。 先月および今月にJMPジャパン事業部で実施したJMP 18の新機能に関するセミナーのアンケートによると、この機能が最も良い機能、使ってみたい機能であると回答がありました...
當今製造業的競爭激烈,企業需要不斷尋求創新的方法來提高效率、降低成本並保持產品品質。在這個動態且複雜的環境中,統計分析工具成為了業界的一大利器,而其中一個廣泛應用的工具就是決策樹。決策樹是一種強大的統計模型,能夠幫助製造業解決各種問題,從產品缺陷分析到生產效率優化,再到供應鏈管理和品質控制。在這篇文章中,我們將探討何謂決策樹,其有哪些應用場景與使用技巧,以應對日益變化的市場需求。 什麼是決策...
實現卓越製造是每個企業追求的⽬標。為了達到這個⽬標,品質部門必須不斷努⼒識別製程變化的來源,並採取適當的措施來控制⽬標。時至科學化的現代,品質單位已經可以透過數據分析的方式,來理解製程的⽣產過程,不僅可以增加⽣產的靈活性,⽽且能確保產品更好地符合客戶要求。 實現智慧製造的三大關鍵 如何基於科學的數據分析實現卓越製造,更是每家企業在要求提升產品品質時,所面臨到的問題。透過過去JMP合作的產...
Society is inundated with data and statistical claims every day and everywhere. Statistical literacy – the ability to interpret and question statistical claims in research, the news, and other commun...
There are 14 or 15 different tools for designing an experiment in JMP, depending on whether you have JMP Pro or not. Here are recommendations for when to use which design tool. Custom Des...
前回のブログ(Part 1) では、JMP 18で強化された「Pyhtonインテグレーション」の機能を用いて、scikit-learnのサンプルデータ「カリフォルニアの住宅価格」をJMPのデータテーブルとして読み込む方法をご紹介しました。 今回のブログ(Part 2)では、読み込んだデータを用いて、住宅価格を築年数、部屋数、緯度、経度などから予測する回帰モデルを作成し、予測...
Odds ratios in a logistic regression model are used to interpret the effect of the factors included in the model. Logistic regression models are widely used throughout industry and academia. They a...
...ports-reference.com.) The stats per year for each QBs were calculated, and a hierarchical clustering analysis was run to group the QBs. (From the cluster analysis, Bryce Young, the first pick of the 2...
To predict the reliability of some parts or products, the time and resources required to test under normal conditions isn’t practical, because it could take years for a failure to occur. Instead, eng...
JMPジャパン事業部では、今年3月から4月にかけて「JMP情報局」というセミナーを毎週火曜日、全8回で実施しました。このセミナーは、毎回30分という短時間でJMPの様々な情報をお伝えすることを目的としており、想定を上回る多くの方々にご参加いただきました。 エンディングで頂いた多くのリアクション 本ブログでは、4月に実施した第5回~第8回で実施...
...nput to a DOE. To illustrate this, I'll use a fictional case study, walking through the necessary steps along with an explanation of what's happening. I've also attached a JMP journal to this blog p...
...hey do not generalize when tested on unseen data? And how do we make sure our models are not unnecessarily complex? One idea that might have occurred to you would be to validate the model against u...
...elow gives an idea of how near-infrared (NIR) data can be collected and analyzed as part of a PAT application. The slide below shows some of the capabilities of JMP Live f...
Enhance your regression analysis with the powerful combination of robust techniques and JMP 18, now featuring seamless integration with Python. Simple Case Study Here's a sample...
One year ago, JMP users who also used Python made it clear they thought our Python interface was less than optimal. Ouch! We thought the JMP and Python integration we introduced more than five years ...
...omponent to regulatory submissions, development of standard operating procedures and maintenance of good manufacturing practices. Different methodologies are used in Bioassay tests. In this blog...
Hey there! You may remember me from my previous stint with JMP Statistical Discovery when I was a member of the Life Sciences group. Well, I’m back, and things are better than ever! Yes, they are....
Have you ever been tasked with predicting who will cancel their services with your company? Or which patients will discontinue their medication? Or perhaps which individuals will be the early adopter...